SCHEMBL4980960

SCHEMBL4980960

NC(=O)c1n[c]c2c(n1)CN(S(=O)(=O)c1ccc(Oc3ccccc3)cc1)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
LMNA P02545 4/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 1/20 0.44
FAAH O00519 1/20 0.42
TSHR P16473 2/20 0.41
HTT P42858 2/20 0.41
MAPT P10636 4/20 0.39
AKR1C3 P42330 2/20 0.39
NR3C1 P04150 1/20 0.39
GBA1 P04062 1/20 0.39
CYP2C9 P11712 1/20 0.38
MMP3 P08254 2/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
MMP14 P50281 1/20 0.38
MMP8 P22894 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4983067 0.92 PKM (0.43) SMN1; SMN2LMNAALDH1A1KMT2ATSHR
SCHEMBL4985245 0.92 LMNA (0.38) SMN1; SMN2LMNAALDH1A1KMT2AFAAH
SCHEMBL4980434 0.91 MMP1 (0.41) SMN1; SMN2LMNAALDH1A1KMT2AHTT
SCHEMBL4988448 0.91 MEN1 (0.45) ALDH1A1KMT2AAKR1C3GBA1CYP2C9
SCHEMBL4982876 0.90 HDAC6 (0.40) SMN1; SMN2LMNAALDH1A1FAAHAKR1C3
SCHEMBL4987011 0.89 PKM (0.46) SMN1; SMN2LMNAALDH1A1KMT2ATSHR
SCHEMBL4989418 0.89 MEN1 (0.37) SMN1; SMN2LMNAALDH1A1KMT2ATSHR
SCHEMBL4982841 0.86 LMNA (0.39) SMN1; SMN2LMNAALDH1A1KMT2AMAPT
SCHEMBL4985224 0.86 AKR1C3 (0.42) KMT2AAKR1C3GBA1
SCHEMBL4987187 0.86 ALDH1A1 (0.46) SMN1; SMN2LMNAALDH1A1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 SMN1; SMN2 4369/4885LMNA 1911/4885ALDH1A1 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.